Published on Thursday April 01, 2021

We are working on the following new projects:

  • Smooth was awarded by 5 projects for medical writing and data management in CEE.

We are happy to reach the following milestones in our projects:

  • All sites were closed in the III phase trial with Risperidone.
  • All patients are enrolled in the Acetylcysteine trial in rhinosinusitis in March.
  • All sites were opened in a III phase trial with Nimesulide.
  • CSR was approved by the Sponsor in the Nadroparin trial.
  • The site was opened in the Dutasteridum + Tamsulosinum bioequivalence study.

We successfully passed ISO certification by G-CERTI (S. Korea) for the following standards:

  • ISO 9001:2015 "Quality Management Systems".
  • ISO 27001:2013 "Information Security Management Systems".
  • ISO 22301:2019 "Business Continuity Management Systems".